Bernstein Weighs In On Vertex Move By: Benzinga via Benzinga June 24, 2014 at 10:58 AM EDT As shares of Vertex Pharmaceuticals (NASDAQ: VRTX) have rallied over 40 percent following a press release concerning phase 3 studies ... Read More >> Related Stocks: Vertex Pharmaceuticals